although
antibiot
ineffect
viral
respiratori
infect
studi
shown
high
rate
prescript
worldwid
conduct
studi
brazil
determin
viral
aetiolog
common
cold
children
describ
use
antibiot
patient
children
year
common
cold
enrol
march
primari
care
level
facil
follow
regular
telephon
call
medic
consult
nasopharyng
wash
obtain
enrol
studi
direct
fluoresc
assay
polymeras
chain
reaction
nine
differ
type
viru
sampl
patient
obtain
median
age
year
respiratori
virus
detect
coinfect
rate
rhinoviru
frequent
viru
follow
influenza
respiratori
syncyti
viru
antibiot
prescript
rate
consid
inappropri
patient
influenza
infect
receiv
antibiot
inappropri
greater
proport
case
compar
respiratori
syncyti
viru
rhinoviru
infect
p
rate
inappropri
use
antibiot
high
patient
influenza
viru
infect
prescrib
antibiot
inappropri
greater
proport
case
common
cold
syndrom
frequent
upper
respiratori
tract
infect
especi
childhood
caus
varieti
differ
respiratori
viru
rhinoviru
influenza
viru
respiratori
syncyti
viru
adenoviru
metapneumoviru
parainfluenza
viru
bocaviru
coronaviru
enteroviru
ruohola
et
al
despit
regard
harmless
diseas
caus
signific
morbid
common
acut
reason
children
visit
primari
care
physician
offic
ahm
et
al
schappert
rechtstein
well
known
antibiot
ineffect
viral
infect
inappropri
use
put
patient
harm
allerg
reaction
antibioticresist
infect
grijalva
et
al
although
decreas
recent
studi
shown
high
rate
antibiot
prescript
viral
respiratori
infect
rang
el
say
et
al
ahm
et
al
secondari
bacteri
infect
sinus
acut
otiti
media
aom
even
pneumonia
occur
common
cold
episod
case
common
cold
follow
selflimit
predict
cours
recognis
usual
sign
symptom
could
avoid
unnecessari
antibiot
therapi
dowel
et
al
combat
spread
resist
bacteria
judici
prescript
antibiot
becom
import
target
medic
organis
worldwid
brandileon
et
al
higashi
fukuhara
order
describ
viral
aetiolog
common
cold
best
address
problem
antibiot
prescript
viral
respiratori
infect
children
conduct
observ
studi
outpati
primari
care
facil
brazil
studi
conduct
march
februari
primari
care
facil
paulo
southeast
region
brazil
children
less
year
age
attend
paediatrician
clinic
diagnosi
code
use
intern
classif
diseas
revis
children
seen
tuesday
friday
morn
diagnosi
common
cold
acut
upper
respiratori
infect
multipl
unspecifi
site
symptom
start
last
five
day
includ
studi
sampl
patient
associ
code
sinus
otiti
media
bacteri
pharyng
pneumonia
underli
chronic
heart
lung
diseas
chronic
health
problem
immun
disord
exclud
patient
use
antibiot
last
five
day
also
exclud
studi
approv
ethic
committe
paulo
feder
univers
cep
written
inform
consent
obtain
parent
guardian
enrol
patient
independ
paediatrician
respons
clinic
intervent
fill
standardis
case
report
form
includ
inform
demograph
characterist
clinic
syndrom
enrol
patient
data
followup
obtain
medic
record
subsequ
offic
visit
also
regular
telephon
call
parent
everi
two
three
day
data
enter
form
resolut
respiratori
ill
data
medic
prescript
antibiot
symptom
day
antibiot
prescript
laboratori
test
xray
exam
report
record
form
use
antibiot
consid
appropri
patient
sign
symptom
secondari
bacteri
infect
diagnos
aom
bacteri
sinus
pneumonia
evid
parenchym
infiltr
chest
xray
exam
patient
diagnosi
sinus
use
antibiot
consid
appropri
case
symptom
rhinosinus
cough
without
improv
day
sever
upper
respiratori
tract
sign
symptom
ie
fever
facial
swell
facial
pain
dowel
et
al
laboratori
test
sampl
nasopharyng
wash
obtain
patient
enrol
visit
median
time
onset
symptom
collect
nasal
wash
three
day
day
sampl
collect
process
use
previous
publish
procedur
immedi
transport
laboratori
respiratori
viru
test
respiratori
sampl
test
first
commerci
panel
simulfluor
respiratori
screen
chemicon
intern
usa
detect
seven
respiratori
virus
respiratori
syncyti
viru
influenza
b
virus
parainfluenza
viru
type
adenoviru
describ
previous
origin
specimen
store
analysi
polymeras
chain
reaction
pcr
test
becam
avail
laboratori
viral
rna
dna
extract
sampl
use
qiaamp
viral
rna
dna
extract
kit
qiagen
usa
accord
manufactur
instruct
nucleic
acid
extract
test
pcr
detect
respiratori
syncyti
viru
influenza
b
virus
adenoviru
rhinoviru
metapneumoviru
bocaviru
coronaviru
enteroviru
accord
publish
method
allard
et
al
savolainen
et
al
falsey
et
al
alland
et
al
brittainlong
et
al
vijgen
et
al
cdc
statist
analysi
statist
analysi
perform
use
spss
stata
statist
softwar
statist
signific
level
test
exist
associ
two
categor
variabl
verifi
use
chisquar
test
fisher
exact
test
depend
sampl
size
student
test
use
perform
comparison
averag
two
group
data
case
independ
sampl
compar
two
averag
analysi
varianc
anova
use
normal
distribut
data
previous
verifi
use
kolmogorovsmirnov
test
nonparametr
mannwhitney
u
kruskalw
test
use
compar
averag
sampl
meet
normal
assumpt
differ
found
averag
multipl
comparison
perform
localis
differ
pairwis
comparison
group
adjust
descript
level
made
overal
signific
whole
studi
medic
consult
carri
code
common
cold
acut
upper
respiratori
infect
multipl
unspecifi
site
common
cold
case
sampl
patient
met
inclus
criteria
obtain
median
age
year
male
frequent
symptom
coryza
cough
fever
wheez
respiratori
virus
detect
nasopharyng
wash
sampl
sampl
per
patient
coinfect
rate
laboratori
test
find
describ
tabl
overal
antibiot
prescript
rate
among
amoxicillin
macrolid
cephalosporin
amoxicillin
plu
sulbactam
tabl
ii
patient
receiv
antibiot
followup
receiv
judici
receiv
inappropri
among
case
inappropri
use
clinic
justif
prescript
antibiot
treat
nasal
postnas
discharg
first
week
common
cold
symptom
patient
without
fever
treat
persist
cough
first
week
symptom
treat
common
cold
treat
wheez
symptom
among
children
fever
onset
symptom
prescrib
antibiot
wherea
fever
onset
symptom
receiv
antibiot
thu
differ
proport
antibiot
prescript
children
fever
onset
symptom
p
total
children
receiv
antibiot
present
fever
onset
symptom
receiv
judici
prescript
antibiot
remain
children
fever
onset
common
cold
symptom
receiv
antibiot
prescrib
antibiot
judici
thu
also
differ
judici
prescript
antibiot
children
fever
without
fever
onset
common
cold
symptom
p
averag
time
resolut
symptom
children
sign
secondari
bacteri
infect
day
within
group
children
receiv
antibiot
among
children
sign
bacteri
infect
averag
time
resolut
symptom
day
group
receiv
antibiot
day
group
among
patient
respiratori
viru
monoinfect
patient
influenza
receiv
antibiot
inappropri
wherea
respiratori
syncyti
viru
prescrib
antibiot
inappropri
rhinoviru
prescrib
antibiot
inappropri
case
p
also
seven
patient
coinfect
influenza
receiv
antibiot
inappropri
show
tabl
ii
none
patient
vaccin
influenza
time
studi
inappropri
use
antibiot
viral
common
cold
import
problem
worldwid
clinic
studi
address
problem
brazil
clinic
cours
common
cold
secondari
bacteri
infect
may
occur
howev
antimicrobi
frequent
use
inappropri
event
normal
clinic
cours
viral
infect
dowel
et
al
studi
practic
particularli
evid
case
viral
rhinosinus
sinc
patient
receiv
antibiot
presenc
nasal
postnas
discharg
first
week
common
cold
symptom
without
fever
childhood
common
cold
complic
aom
wald
et
al
chonmaitre
et
al
although
current
recommend
manag
aom
encourag
initi
observ
nonsever
aom
case
select
children
ie
watch
wait
aap
still
controversi
around
diagnosi
manag
aom
routin
practic
diagnosi
aom
frequent
consid
difficulti
confirm
diagnosi
studi
consid
indic
antibiot
aom
adequ
regardless
patient
age
sever
symptom
certainti
diagnosi
believ
rate
inappropri
use
antibiot
could
even
greater
stringent
diagnost
criteria
appli
aom
diagnosi
amoxicillin
first
choic
antibiot
therapi
account
prescript
hand
second
prescrib
antibiot
macrolid
accord
anc
current
guidelin
bradley
et
al
predominantli
paediatr
outpati
popul
grow
emerg
bacteri
resist
macrolid
relat
delay
cure
respons
great
proport
cost
current
associ
antibiot
resist
pneumococc
infect
kawai
et
al
reynold
et
al
antibiot
also
teach
best
practic
antibiot
therapi
could
great
help
improv
scenario
diagnost
uncertainti
defin
difficulti
distinguish
selflimit
viral
infect
bacteri
infect
requir
antibiot
therapi
identifi
research
factor
contribut
antibiot
overus
arnold
et
al
thu
difficulti
predict
bacteri
infect
febril
children
could
lead
misus
antibiot
bacteri
infect
associ
worsen
clinic
condit
consequ
longer
time
resolut
symptom
howev
common
cold
without
secondari
infect
follow
selflimit
cours
day
reduct
durat
symptom
use
antibiot
observ
studi
report
elsewher
medic
literatur
kaiser
et
al
brandileon
et
al
li
et
al
carranzamartinez
et
al
although
studi
design
evalu
influenc
fever
medic
decis
prescrib
antibiot
observ
differ
proport
antibiot
prescript
patient
fever
onset
symptom
well
proport
judici
prescript
antibiot
two
group
patient
addit
research
need
identifi
local
factor
determin
antibiot
misus
although
well
known
influenza
vaccin
primari
strategi
prevent
influenza
brazilian
health
ministri
start
public
vaccin
campaign
influenza
children
part
popul
access
influenza
vaccin
time
studi
none
patient
studi
vaccin
influenza
fact
could
explain
high
frequenc
influenza
infect
patient
show
tabl
antivir
treatment
also
play
import
role
decreas
influenzarel
morbid
mortal
none
patient
laboratori
confirm
influenza
infect
receiv
antivir
therapi
wherea
patient
influenza
monoinfect
receiv
antibiot
inappropri
coinfect
influenza
virus
also
receiv
antibiot
inappropri
great
proport
case
recent
studi
unit
state
america
report
antivir
medic
underprescrib
antibiot
may
inappropri
prescrib
larg
proport
outpati
influenza
haver
et
al
refer
studi
emphasis
use
sensit
specif
test
rapid
diagnosi
influenza
respiratori
virus
strongli
recommend
could
decreas
antibiot
use
guid
appropri
use
antivir
agent
outpati
inpati
set
bradley
et
al
brazil
diagnost
test
respiratori
viru
still
expens
easili
avail
vast
major
popul
especi
low
incom
peopl
studi
conduct
one
primari
care
facil
possibl
generalis
result
brazilian
primari
health
care
servic
howev
preliminari
data
help
us
better
understand
antibiot
misus
among
children
common
cold
viral
infect
believ
continu
educ
appropri
antibiot
antivir
use
well
access
influenza
vaccin
sensit
specif
test
rapid
diagnosi
respiratori
virus
antivir
medic
essenti
improv
primari
healthcar
qualiti
